617 research outputs found
Strengthening a school-community relations program through student involvement
This study\u27s main purpose was to show the logic and benefits of involving students in school-community relations. The data collection consisted of online and library searches for information about schools that include students in their public relations efforts. Award-winning newsletters from 42 school districts were also examined to determine consistent qualities that lead to excellence in communications.
The study showed that while students are directly and indirectly involved in school-community relations on a continuing, daily basis, little has been documented about structured programs or formal involvement. Research supports the effectiveness of student involvement, yet few districts make a conscious effort to capitalize upon their most valuable resource. Ongoing, cognizant efforts to involve students in public relations opportunities can yield great benefits for school districts
The Wellbeing Index: A Landscape of Worldwide Measures and the Potential for Large-Scale Change
Around the world, across a spectrum of disciplines and by many different pathways, measures of wellbeing are emerging as a means for institutions and individuals to join forces in their efforts to balance material growth and development with the rights of humans to preserve, protect, and pursue those interests that lead to wellbeing, for both individuals and for society. Wellbeing indices are an important and innovative addition to the global conversation about the economics of happiness. Their rising viability with nations, communities, Nobel laureates, ordinary citizens, academics, economists, and policymakers, speaks to a growing questioning of the validity and adequacy of traditional measures of national progress – notably, the gross domestic product. Through the lens of positive psychology, this capstone provides an overview of the landscape of wellbeing indices, identifying in one place who is measuring what, by what indicators, and why. As scientific interest in the measurement of population wellbeing and national performance begins to deliver and document empirical results, this capstone makes a case for the wellbeing index as an instrument of massively disruptive and contagious change –a grand-scale positive intervention that has the potential to change the world
Impact of Individualized Professional Development Plans on Improving Instructional Strategies in the Classroom
School of Teaching, Learning and Educational Science
Impacts of Extension Education on Improving Residential Stormwater Quality: Monitoring Results
The project reported in this article evaluated whether stormwater quality could be improved by educating homeowners and implementing best management practices in a suburban neighborhood. Nitrogen, phosphorus, and bacteria levels from two watersheds were compared using the paired watershed approach. Resident surveys, property site assessments, soil tests, and water quality and quantity monitoring were conducted. A x2-analysis of survey data indicated no significant changes in measured behavior. Significant (p=0.01) reductions in NO3-N and fecal coliform bacteria concentrations occurred; however, total nitrogen concentrations did not change significantly
Comparison of Chemotherapeutic Activities of Rhodamine-Based GUMBOS and NanoGUMBOS
Rhodamine derivatives have been widely investigated for their mitochondrial targeting and chemotherapeutic properties that result from their lipophilic cationic structures. In previous research, we have found that conversion of Rhodamine 6G into nanoGUMBOS, i.e., nanomaterials derived from a group of uniform materials based on organic salts (GUMBOS), led to selective chemotherapeutic toxicity for cancer cells over normal cells. Herein, we investigate the chemotherapeutic activity of GUMBOS derived from four different rhodamine derivatives, two bearing an ester group, i.e., Rhodamine 123 (R123) and SNAFR-5, and two bearing a carboxylic acid group, i.e., rhodamine 110 (R110) and rhodamine B (RB). In this study, we evaluate (1) relative hydrophobicity via octanol–water partition coefficients, (2) cytotoxicity, and (3) cellular uptake in order to evaluate possible structure–activity relationships between these different compounds. Intriguingly, we found that while GUMBOS derived from R123 and SNAFR-5 formed nanoGUMBOS in aqueous medium, no distinct nanoparticles are observed for RB and R110 GUMBOS. Further investigation revealed that the relatively high water solubility of R110 and RB GUMBOS hinders nanoparticle formation. Subsequently, while R123 and SNAFR-5 displayed selective chemotherapeutic toxicity similar to that of previously investigated R6G nanoGUMBOS, the R110 and RB GUMBOS were lacking in this property. Additionally, the chemotherapeutic toxicities of R123 and SNAFR-5 nanoGUMBOS were also significantly greater than R110 and RB GUMBOS. Observed results were consistent with decreased cellular uptake of R110 and RB as compared to R123 and SNAFR-5 compounds. Moreover, these results are also consistent with previous observations that suggest that nanoparticle formation is critical to the observed selective chemotherapeutic properties as well as the chemotherapeutic efficacy of rhodamine nanoGUMBOS
Recommended from our members
Recruitment and retention of participants in a pragmatic randomized intervention trial at three community health clinics: Results and lessons learned
Background: Obesity and hypertension and their associated health complications disproportionately affect communities of color and people of lower socioeconomic status. Recruitment and retention of these populations in research trials, and retention in weight loss trials has been an ongoing challenge. Methods: Be Fit, Be Well was a pragmatic randomized weight loss and hypertension management trial of patients attending one of three community health centers in Boston, Massachusetts. Participants were asked to complete follow-up assessments every 6-months for two years. We describe challenges encountered and strategies implemented to recruit and retain trial participants over the 24-month intervention. We also identify baseline participant characteristics associated with retention status. Retention strategies included financial incentives, contact between assessment visits, building relationships with health center primary care providers (PCPs) and staff, and putting participant convenience first. Results: Active refusal rates were low with 130 of 2,631 patients refusing participation (4.9%). Of 474 eligible persons completing telephone screening, 365 (77.0%) completed their baseline visit and were randomized into the study. The study population was predominantly non-Hispanic Black (71.2%), female (68.5%) and reported annual household income of less than $35,000 (70.1%). Recruitment strategies included use of passive approval of potential participants by PCPs, use of part-time staff, and outsourcing calls to a call center. A total of 314 (86.0%) people completed the 24-month visit. Retention levels varied across study visits and intervention condition. Most participants completed three or more visits (69.6%), with 205 (56.2%) completing all four. At 24-months, lower retention was observed for males and the intervention condition. Retention strategies included building strong relationships with clinic staff, flexibility in overcoming participant barriers through use of taxi vouchers, night and weekend appointments, and keeping participants engaged via newsletters and social gatherings. Conclusion: We were able to retain 86.0% of participants at 24-months. Recruitment and retention of high percentages of racial/ethnic minorities and lower income samples is possible with planning, coordination with a trusted community setting and staff (e.g. community health centers and RAs), adaptability and building strong relationships. Trial registration Clinicaltrials.gov Identifier: NCT0066181
EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment
The main aim of health technology assessment (HTA) is to inform decision making by health care policy makers. It is a systematic process that evaluates the use of health technologies and generally involves a critical review of international evidence related to clinical effectiveness of the health technology vs. the best standard of care. It can also include an evaluation of cost effectiveness, and social and ethical impacts in the local health care system. The HTA process advises whether or not a health technology should be used, and if so, how it is best used and which patients are most likely to benefit from it. The importance of patient involvement in HTA is becoming widely recognized, for scientific and democratic reasons. The extent of patient involvement in HTA varies considerably across Europe. Commonly HTA is still focused on quantitative evidence to determine clinical and/or cost effectiveness, but the interest in understanding patients' experiences and preferences is increasing. Some HTA bodies provide support for participation in their processes, but again this varies widely across Europe. The involvement of patients in HTA is determined at the national and regional level, and is not subject to any European-wide legislation. The guidance text presented in this article was developed as part of the work of the European Patients' Academy on Therapeutic Innovation (EUPATI) and covers the interaction between HTA bodies and patients and their representatives when medicines are being assessed. Other EUPATI guidance documents relate to patient involvement in pharmaceutical industry-led research and development, ethics committees, and regulatory authorities. The guidance provides recommendations for activities to support patient involvement in HTA bodies and specific guidance for individual HTA processes. It seeks to improve patient involvement, using the outcomes of published research and consensus-building exercises. It also draws on good practice examples from individual HTA bodies. The guidance is not intended to be prescriptive and should be used according to specific circumstances, national legislation, or the unique needs of each interaction. This article represents the formal publication of the HTA guidance text with discussion about recent progress in, and continuing barriers to, patient involvement in HTA
- …